Preclinical Studies of Chiauranib Show It Inhibits Transformed Follicular Lymphoma through the VEGFR2/ERK/STAT3 Signaling Pathway

Transformed follicular lymphoma (t-FL), for which there is no efficient treatment strategy, has a rapid progression, treatment resistance, and poor prognosis, which are the main reasons for FL treatment failure. In this study, we identified a promising therapeutic approach with chiauranib, a novel o...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Yuanfang Tang, Mengya Zhong, Guangchao Pan, Jinshui Tan, Chendi Xie, Yuelong Jiang, Jingwei Yao, Weihang Shan, Jiaqi Lin, Jiewen Huang, Yating Liu, Zhifeng Li, Bing Xu, Jie Zha
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	MDPI AG 2022-12-01
Reeks:	Pharmaceuticals
Onderwerpen:	transformed follicular lymphoma (t-FL) chiauranib VEGFR2 VEGFR2/ERK/STAT3 signaling pathway
Online toegang:	https://www.mdpi.com/1424-8247/16/1/15
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!